DNASE1L3 and cancer: DNases regarded as a promising personalized gene-based therapy for cancer has received a great deal of attention, several apoptotic endonucleases have been identified, the inhibition of both alkaline DNase (DNase I) and acid DNase (DNase II) has been reported in non-necrotic cancer cells at the early stages of experimental carcinogenesis 9.